Featured Research

from universities, journals, and other organizations

Details Of Promising Cancer Therapy Shows For The First Time

Date:
June 2, 1999
Source:
American Chemical Society
Summary:
Scientists at Schering-Plough Research Institute are reporting what they say is the first atomic view that shows how a promising new class of cancer-fighting drugs works. The discovery may point the way to faster, better refinement of the drugs, according to the researchers. Several pharmaceutical companies are in a race to develop so-called farnesyl protein transferase (FPT) inhibitors, which incapacitate an enzyme recently found to activate many types of cancer.

Visualization of action could lead to development of more potent, less toxic drugs

Scientists at Schering-Plough Research Institute are reporting what they say is the first atomic view that shows how a promising new class of cancer-fighting drugs works. The discovery may point the way to faster, better refinement of the drugs, according to the researchers. Several pharmaceutical companies are in a race to develop so-called farnesyl protein transferase (FPT) inhibitors, which incapacitate an enzyme recently found to activate many types of cancer. The drug detailed in this study is currently in clinical trials.

The findings will appear in the Journal of Medicinal Chemistry, which is published by the American Chemical Society (ACS), the world's largest scientific society. The peer-reviewed paper will be available on the ACS Web June 2 and is tentatively scheduled to appear in the journal's July 1 print edition.

FPT puts the finishing touches on a protein made under the direction of a mutated gene called ras (short for "rat sarcoma" because the gene's cancer connection was originally discovered in rats). Normally, a completed Ras protein attaches to cell membranes where it signals cells to grow, when appropriate. The mutation, which causes a single kink in the Ras protein structure, leaves it stuck in the "on" position. Out of control growth then ensues, causing cancer.

Since the gene's discovery in the early 1990s, the ras mutation has been linked to 90 percent of pancreatic cancers, 50 percent of colon cancers, and 30 percent of lung cancers. Researchers hope that by attacking FPT, instead of cell replication machinery directly, they can more specifically inhibit cancer and lessen collateral damage to normal cells.

A wave of FPT inhibitors has recently surged into clinical trials. They are one of the first types of mechanism-based anti-cancer agents targeted at a known protein molecule. While scientists had ideas about how FPT inhibitors fouled up the enzyme, the current study used crystallographic analysis to actually view the interaction. "It is a validation that these compounds do bind to the active site of the farnesyl protein transferase," according to co-author and Schering-Plough Research Institute chemist Patricia Weber, Ph.D. The study specifically looks at Schering-Plough's clinical candidate, SCH 66336, which is in phase II efficacy trials directed against a variety of solid tumors. While the company maintains that no trial results are available yet, Weber says the new images "allow a detailed understanding of how and why these inhibitors work -- and it is our expectation that, in the future, the combination of synthetic chemistry and x-ray crystallography will lead to the development of more potent, second generation FPT inhibitors."

Among the other pharmaceutical companies developing FPT inhibitors are Johnson & Johnson, Merck, Bristol-Myers Squibb, Warner-Lambert, Abbott Laboratories and Rhone-Poulenc Rorer, Inc.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Cite This Page:

American Chemical Society. "Details Of Promising Cancer Therapy Shows For The First Time." ScienceDaily. ScienceDaily, 2 June 1999. <www.sciencedaily.com/releases/1999/06/990602072418.htm>.
American Chemical Society. (1999, June 2). Details Of Promising Cancer Therapy Shows For The First Time. ScienceDaily. Retrieved August 1, 2014 from www.sciencedaily.com/releases/1999/06/990602072418.htm
American Chemical Society. "Details Of Promising Cancer Therapy Shows For The First Time." ScienceDaily. www.sciencedaily.com/releases/1999/06/990602072418.htm (accessed August 1, 2014).

Share This




More Health & Medicine News

Friday, August 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

House Republicans Vote to Sue Obama Over Healthcare Law

House Republicans Vote to Sue Obama Over Healthcare Law

Reuters - US Online Video (July 31, 2014) The Republican-led House of Representatives votes to sue President Obama, accusing him of overstepping his executive authority in making changes to the Affordable Care Act. Mana Rabiee reports. Video provided by Reuters
Powered by NewsLook.com
Despite Health Questions, E-Cigs Are Beneficial: Study

Despite Health Questions, E-Cigs Are Beneficial: Study

Newsy (July 31, 2014) Citing 81 previous studies, new research out of London suggests the benefits of smoking e-cigarettes instead of regular ones outweighs the risks. Video provided by Newsy
Powered by NewsLook.com
Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins